FDA drafts two guidances on safety testing for cell and gene therapy products
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Quality Assurance and ControlRegulatory Intelligence/PolicyUnited States